http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0111058-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0939c5e9137698ff8a8d8ddaa5ee7bf0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2001-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ca0edc37e5c9ddba21bcc7cfd823fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1423043b2c1f347232a4701f5da5a23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6660e289b04471009340c44eefdfae2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d026e2c129c79aec44fd01f8a1ec68b
publicationDate 2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0111058-A
titleOfInvention Mesoprogestin 11 beta- [4- (hydroxyiminomethyl) -phenyl] -17 alpha-methoxymethyl-17 beta-methoxy-estra-4,9-dien-3-one solid forms
abstract "Forms of 11 BETA- [4E- (HYDROXYIMINOMETHYL) -Phenyl] -17 ALPHA-METOXYMETHYL-17 BETA-METOXY-STRA-4,9-DIEN-3-ONA SOLES". The invention relates to novel solid body forms of 11β - [4E- (hydroxyiminomethyl) phenyl] -17β-methoxymethyl-17β-methoxy-estra-4,9-dien-3-one mesoprogestin (oxime J867), particularly a highly pure and stable highly crystalline or amorphous (non-solvate / non-hydrate) form of compound J867. The invention also relates to methods for producing said novel solid body forms and their use in pharmaceutical compositions. The new solid body shapes are characterized by displaying a high degree of stability. Oxime J867 solid body forms may in particular be employed in the area of fertility control and hormone replacement therapy.
priorityDate 2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 26.